PACB Stock Analysis: Buy, Sell, or Hold?
PACB - Pacific Biosciences of California, Inc.
$2.11
0.05 (2.43%)
â˛
5d:
+21.97%
30d:
+33.54%
90d:
+55.15%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 04, 2026
10d
Get Alerted When PACB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: PACB is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: PACB is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: PACB is currently trading at $2.11, which is considered fair relative to its 30-day fair value range of $1.48 to $2.39.
Technical Outlook: Technically, PACB is in a uptrend. Immediate support is located at $1.70, while resistance sits at $2.29.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.40 (+13.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PACB is in a uptrend. Immediate support is located at $1.70, while resistance sits at $2.29.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.40 (+13.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.48 -
$2.39
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
Protect Your Profits
Holding PACB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($2.40)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.48 -
$2.39
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.70
Resistance Level
$2.29
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.01
Wall Street Target
$2.40
(+13.7%)
Revenue Growth (YoY)
-1.9%
Profit Margin
-82.5%
Share & Embed Analysis
Last updated: October 24, 2026 12:19 PM ET
Data refreshes hourly during market hours. Next update: 1:19 PM
Data refreshes hourly during market hours. Next update: 1:19 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PACB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 46 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 41 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 38 SELL |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 70 BUY |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$167 | 37 SELL |
Advanced PACB Option Strategies
Professional options setups generated by AI based on today's PACB price and gamma walls.
